• What's new in PAH in 2024

  • Sep 30 2024
  • Duración: 34 m
  • Podcast
  • Resumen

  • Dr. Melissa Wilson discusses new treatments in the field of pulmonary hypertension in 2024, focusing on Sotatercept and combination therapy with Opsynvi. Dr. Wilson emphasizes the importance of patient selection and individualized treatment plans. She also discusses the initiation and monitoring of these therapies, as well as potential side effects and patient adherence.

    Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA.
    Visit our website for more APP Pulmonary, Critical Care, and Sleep Medicine content and free CMEs www.pulmapp.com
    Follow us on:

    • Instagram @pulmapps
    • Twitter @pulmapp
    • Facebook @association of pulmonary advance practice providers.
    Más Menos
adbl_web_global_use_to_activate_webcro805_stickypopup

Lo que los oyentes dicen sobre What's new in PAH in 2024

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.